Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FHBQ8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,953
Award facts
- Contract value 100% obligated
- $20,953.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order for 68 mg Nexplanon implants valued at $20,953.25 under a firm fixed-price arrangement. The delivery order, issued on January 5, 2026, with completion targeted for January 27, 2026, utilizes no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. This award is executed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying diverse pharmaceutical products to support Department of Defense military healthcare operations globally.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with the PPV-G GEN V contract providing a $499.999 billion ceiling and extending through December 31, 2036. The company's product portfolio encompasses an extensive range including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals including contraceptive devices such as Nexplanon implants. As a verified supplier since 2001, DMS Pharmaceutical Group has demonstrated substantial performance across numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, positioning the vendor to fulfill specialized pharmaceutical requirements for military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FHBQ8?
SPE2DR26FHBQ8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FHBQ8 worth?
The government has obligated $20,953 on SPE2DR26FHBQ8.
Is contract SPE2DR26FHBQ8 an order under another contract?
Yes. SPE2DR26FHBQ8 is a delivery order under SPE2DR25D9202, an indefinite delivery contract.
Was contract SPE2DR26FHBQ8 competed?
The extent of competition for SPE2DR26FHBQ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award